Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
THR-β agonist 2
Cat. No.:
OB0425LY-138
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
THR-β agonist 2 A selective agonist that acts primarily on the thyroid hormone receptor beta subtype (THR-β). The compound regulates metabolism, cell growth and differentiation by activating THR-β.
Synonyms:
2440027-77-8; THR-beta agonist ; 2-[3,5-Dichloro-4-[(3,4-dihydro-4-oxo-1-phthalazinyl)oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carbonitrile
CAS No.:
2440027-77-8
Compound CID:
153610319
Formula:
C18H8Cl2N6O4
Formula Weight:
443.2
Specification
Target:
Thyroid hormone receptor
Pathway:
Vitamin D related/Nuclear receptor
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
THR-β agonist 2 can be used to study diseases associated with metabolic disorders such as obesity, diabetes and other metabolic syndromes.
